Alligator Bioscience: Positive Data from MesoPher Trial - Redeye
Redeye comments on the phase I data generated from a phase I study combining MesoPher with mitazalimab. It resulted in stable disease and T-cell activation.
ANNONS
Redeye comments on the phase I data generated from a phase I study combining MesoPher with mitazalimab. It resulted in stable disease and T-cell activation.
